162506-58-3 Usage
Uses
Used in Pharmaceutical Industry:
4-Methyl-1,3-benzodioxole-5-carboxylic acid is used as a chemical intermediate for the synthesis of various drugs, particularly in the development of medications targeting hypertension and cardiovascular diseases. Its unique structure and properties make it a valuable component in the creation of effective pharmaceuticals.
Used in Drug Development:
4-Methyl-1,3-benzodioxole-5-carboxylic acid is utilized in drug development as a potential therapeutic agent for the treatment of hypertension and cardiovascular diseases. Its investigation into these areas is due to its potential to modulate physiological pathways and mechanisms associated with these conditions, thereby contributing to improved patient outcomes.
Used in Research and Development:
4-Methyl-1,3-benzodioxole-5-carboxylic acid is also used in research and development settings to explore its potential applications and therapeutic properties. Scientists and researchers are investigating its pharmacological effects and how it can be optimized for use in medical treatments.
Safety and Handling:
It is crucial to handle 4-Methyl-1,3-benzodioxole-5-carboxylic acid with care due to its potential health risks if not properly managed. Safe handling protocols and disposal methods are essential to minimize any adverse effects on human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 162506-58-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,5,0 and 6 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 162506-58:
(8*1)+(7*6)+(6*2)+(5*5)+(4*0)+(3*6)+(2*5)+(1*8)=123
123 % 10 = 3
So 162506-58-3 is a valid CAS Registry Number.
162506-58-3Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK
-
Page/Page column 46, (2012/11/08)
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
CERTAIN SUBSTITUTED PYRIMIDINES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR THEIR USE
-
Page/Page column 163, (2010/11/03)
Provided are certain Hsp90 inhibitors, i.e., compounds of Formula I and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods for their use and preparation.
Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
-
Page/Page column 32; 33, (2010/02/14)
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand
Herbicidal isoxazoles
-
, (2008/06/13)
The invention relates to isoxazole derivatives of formula (I): STR1 wherein: Ar represents phenyl optionally substituted by from one to three groups and wherein two substituents on adjacent positions of the phenyl ring, together with the two atoms to whic
